BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 36865559)

  • 1. Macrophage: Key player in the pathogenesis of autoimmune diseases.
    Yang S; Zhao M; Jia S
    Front Immunol; 2023; 14():1080310. PubMed ID: 36865559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes.
    Frazzei G; van Vollenhoven RF; de Jong BA; Siegelaar SE; van Schaardenburg D
    Front Immunol; 2022; 13():899372. PubMed ID: 35844538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of CD38 protein as a target for autoimmune diseases.
    Ye X; Zhao Y; Ma W; Ares I; Martínez M; Lopez-Torres B; Martínez-Larrañaga MR; Wang X; Anadón A; Martínez MA
    Autoimmun Rev; 2023 Apr; 22(4):103289. PubMed ID: 36750136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Potential of Galectin-1 and Galectin-3 in Autoimmune Diseases.
    He YS; Hu YQ; Xiang K; Chen Y; Feng YT; Yin KJ; Huang JX; Wang J; Wu ZD; Wang GH; Pan HF
    Curr Pharm Des; 2022; 28(1):36-45. PubMed ID: 34579628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin in autoimmune disorders: current knowledge and future perspective.
    Xu C; Wu Y; Liu N
    Inflammopharmacology; 2022 Apr; 30(2):385-396. PubMed ID: 35235108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
    El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
    Front Immunol; 2021; 12():643170. PubMed ID: 33732263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cells - Dr. Jekyll and Mr. Hyde in autoimmune rheumatic diseases.
    Hojjatipour T; Aslani S; Salimifard S; Mikaeili H; Hemmatzadeh M; Gholizadeh Navashenaq J; Ahangar Parvin E; Jadidi-Niaragh F; Mohammadi H
    Int Immunopharmacol; 2022 Jun; 107():108682. PubMed ID: 35259710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases.
    Blanco LP; Kaplan MJ
    PLoS Biol; 2023 Apr; 21(4):e3002084. PubMed ID: 37098006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of macrophages to systemic lupus erythematosus.
    Ma C; Xia Y; Yang Q; Zhao Y
    Clin Immunol; 2019 Oct; 207():1-9. PubMed ID: 31255802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte and macrophage abnormalities in systemic lupus erythematosus.
    Li Y; Lee PY; Reeves WH
    Arch Immunol Ther Exp (Warsz); 2010 Oct; 58(5):355-64. PubMed ID: 20676786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of vitamin D levels in autoimmune diseases.
    Marques CD; Dantas AT; Fragoso TS; Duarte AL
    Rev Bras Reumatol; 2010; 50(1):67-80. PubMed ID: 21125142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy and Autoimmune Diseases.
    Jin M; Zhang Y
    Adv Exp Med Biol; 2020; 1207():405-408. PubMed ID: 32671763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microRNAs in the pathogenesis of autoimmune diseases.
    Chen JQ; Papp G; Szodoray P; Zeher M
    Autoimmun Rev; 2016 Dec; 15(12):1171-1180. PubMed ID: 27639156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras family signaling pathway in immunopathogenesis of inflammatory rheumatic diseases.
    Sadeghi Shaker M; Rokni M; Mahmoudi M; Farhadi E
    Front Immunol; 2023; 14():1151246. PubMed ID: 37256120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-13: A promising therapeutic target for autoimmune disease.
    Mao YM; Zhao CN; Leng J; Leng RX; Ye DQ; Zheng SG; Pan HF
    Cytokine Growth Factor Rev; 2019 Feb; 45():9-23. PubMed ID: 30581068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of semaphorins in immune responses and autoimmune rheumatic diseases.
    Nishide M; Kumanogoh A
    Nat Rev Rheumatol; 2018 Jan; 14(1):19-31. PubMed ID: 29213125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Alterations in Cellular Immunity: New Insights into Autoimmune Diseases.
    Wang Z; Lu Q; Wang Z
    Cell Physiol Biochem; 2017; 41(2):645-660. PubMed ID: 28214857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed cell death in autoimmune diseases: ferroptosis.
    Sun J; Huang L; Wang J; Hu Y; Wang W; Zhu H
    Ann Biol Clin (Paris); 2024 Apr; 82(1):33-42. PubMed ID: 38638017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging roles of exosomes in autoimmune diseases, with special emphasis on microRNAs in exosomes.
    Miao C; Wang X; Zhou W; Huang J
    Pharmacol Res; 2021 Jul; 169():105680. PubMed ID: 34010670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
    Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
    Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.